BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

USFDA Approves Treatment for Wider Range of Patients with Heart Failure

Jardiance was originally approved by the FDA in 2014 as a supplement to diet and exercise to improve glucose control in adults with type 2 diabetes. Jardia...

February 28, 2022 | News

GSK has launched the inaugural Shingles Awareness Week

GSK has launched the inaugural Shingles Awareness Week to educate the general public about shingles in collaboration with the International Federation on...

February 28, 2022 | News

RosVivo signed MTA for diabetes treatment with Eli Lilly and Company

RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...

February 23, 2022 | News

Johns Hopkins to Offer Free Online Course for Consumer Health

Join the thousands of tobacco control professionals from across the globe who have expanded their knowledge on key issues by taking the free online course ...

February 22, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...

February 21, 2022 | News

Analysis of DNA reveals weapons used by our immune cells to fight Tuberculosis

The team used high-throughput genomic technologies to learn how the DNA packaging inblood cells changes when a person has active TB, a bacterial disease th...

February 17, 2022 | News

Two Million Euros for XO Life GmbH's Patient Insights Platform

MedTech startup XO Life, based in Berlin and Munich, raised more than €2 million to further build its patient insights platform for drugs and the...

February 17, 2022 | News

Scientists breaking barriers to treating heart failure

Ceryx Medical Limited, together with scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, has developed tech...

February 16, 2022 | News

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

February 11, 2022 | News

Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process AUCKLAND...

February 03, 2022 | News

Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug

Daewoong Pharmaceutical (Daewoong) has confirmed promising phase 3 topline results that focuses on the therapeutic effects as an Enavogliflozin monotherapy...

January 26, 2022 | News

AHF Praises Merck for Generics – Urges Same from Vaccine Makers

“We praised Merck last October for its voluntary licensing agreement with MPP. Their efforts are now coming to fruition with an affordable ...

January 25, 2022 | News

HMI Group Strengthens Specialist Offering, Acquires Majority Stake in Eagle Eye Centre

Health Management International Pte Ltd (HMI Group), a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia, has...

January 25, 2022 | News

NMN Supplement: A Promising Anti-Aging Product or Still An Encouraging Lab Experiment With Ongoing Clinical Trials?

However, the effect of time on the human biology is such that no matter how cautious we remain on the fronts of physical activity as well as diet, age alwa...

January 23, 2022 | News | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Stay Connected